Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 1;29(9):1275-1284.
doi: 10.5551/jat.63159. Epub 2021 Sep 25.

Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication

Masato Furuhashi  1 , Yu Kataoka  2 , Ryo Nishikawa  1 , Masayuki Koyama  1   3 , Akiko Sakai  1 , Yukimura Higashiura  1 , Marenao Tanaka  1 , Shigeyuki Saitoh  1   4 , Kazuaki Shimamoto  5 , Hirofumi Ohnishi  1   3
Affiliations

Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication

Masato Furuhashi et al. J Atheroscler Thromb. .

Abstract

Aim: Dyslipidemia and altered iron metabolism are typical features of non-alcoholic fatty liver disease (NAFLD). Proprotein convertase subtilisin/kexin type 7 (PCSK7), a transmembrane-anchored endonuclease, is associated with triglycerides level and processing of transferrin receptor 1. However, the significance of circulating PCSK7 has not been fully addressed, though prosegment PCSK7 is secreted from cells. We investigated the associations of plasma PCSK7 level with several parameters.

Methods: Plasma PCSK7 concentration was measured in 282 subjects (male/female: 126/156) without medication of the Tanno-Sobetsu Study, a population-based cohort study.

Results: There was no significant sex difference in PCSK7 level. Current smoking habit, but not alcohol drinking habit, was associated with increased PCSK7 level. PCSK7 concentration was negatively correlated with age and blood urea nitrogen and was positively correlated with body mass index (BMI) and levels of γ-glutamyl transpeptidase (γGTP), triglycerides and fatty liver index (FLI), which is calculated by BMI, waist circumference and levels of γGTP and triglycerides, as a noninvasive and simple predictor of NAFLD. There were no significant correlations of PCSK7 level with levels of iron and plasma PCSK9, a secreted PCSK family member and a regulator of low-density lipoprotein cholesterol level. Multivariable regression analyses after adjustment of age, sex and current smoking habit showed that PCSK7 concentration was independently associated with BMI (β=0.130, P=0.035), triglycerides (β=0.141, P=0.027) or FLI (β=0.139, P=0.030).

Conclusions: Plasma PCSK7 concentration is independently associated with chronic liver disease including obesity and elevated triglycerides level in a general population of individuals who had not regularly taken any medications.

Keywords: Fatty liver; Obesity; Proprotein convertase subtilisin/kexin type 7; Triglycerides.

PubMed Disclaimer

Figures

Fig.1. Comparisons of PCSK7 level by habits of smoking and alcohol drinking
Fig.1. Comparisons of PCSK7 level by habits of smoking and alcohol drinking
A, B. Comparisons of proprotein convertase subtilisin/kexin type 7 (PCSK7) in subjects with and those without habits of current smoking (-/+: 214/68) (A) and alcohol drinking (-/+: 164/118) (B) shown by box plots. Variables are expressed as means±SD. ＊P＜0.05.
Fig.2. Correlations of PCSK7 level with parameters
Fig.2. Correlations of PCSK7 level with parameters
A-F. Age (A), body mass index (B), logarithmically transformed (log) triglycerides (C) and log fatty liver index (FLI) (D) were plotted against PCSK7 level in each subject (n=282). Open circles: males (n=126), closed circles: females (n=156).
See this image and copyright information in PMC

Comment in

  • Can PCSK7 be A New Pharmaceutical Target?
    Kawashiri MA. Kawashiri MA. J Atheroscler Thromb. 2022 Sep 1;29(9):1265-1267. doi: 10.5551/jat.ED188. Epub 2022 Jan 15. J Atheroscler Thromb. 2022. PMID: 35034921 Free PMC article. No abstract available.

References

    1. Artenstein AW, Opal SM: Proprotein convertases in health and disease. N Engl J Med, 2011; 365: 2507-2518 - PubMed
    1. Seidah NG, Prat A: The biology and therapeutic targeting of the proprotein convertases. Nat Rev Drug Discov, 2012; 11: 367-383 - PubMed
    1. Turpeinen H, Ortutay Z, Pesu M: Genetics of the first seven proprotein convertase enzymes in health and disease. Curr Genomics, 2013; 14: 453-467 - PMC - PubMed
    1. Lambert G, Sjouke B, Choque B, Kastelein JJ, Hovingh GK: The PCSK9 decade. J Lipid Res, 2012; 53: 2515-2524 - PMC - PubMed
    1. Schmidt RJ, Zhang Y, Zhao Y, Qian YW, Wang H, Lin A, Ehsani ME, Yu X, Wang G, Singh J, Su EW, Li S, Konrad RJ, Cao G: A novel splicing variant of proprotein convertase subtilisin/kexin type 9. DNA Cell Biol, 2008; 27: 183-189 - PubMed